Lindsey Rolfe - May 30, 2025 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Role
Director
Signature
/s/ Andrew Kucharchuk, Attorney-in-Fact
Stock symbol
CERO
Transactions as of
May 30, 2025
Transactions value $
$0
Form type
4
Date filed
6/2/2025, 05:06 PM
Previous filing
Mar 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rolfe Lindsey Director CERO THERAPEUTICS HOLDINGS, INC., 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO /s/ Andrew Kucharchuk, Attorney-in-Fact 2025-06-02 0001650504

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERO Stock Option (Right to Buy) Award $0 +9.33K $0.00 9.33K May 30, 2025 Common Stock 9.33K $0.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the 1/3 time-based portion of an award of options to purchase 27,979 shares, vesting in equal monthly installments on the 4th of each month from July 4, 2025 through March 4, 2026, with the remaining portion subject to performance conditions.

Remarks:

Exhibit 24 - Power of Attorney.